Ying‐Wei Lan

1.2k total citations
40 papers, 837 citations indexed

About

Ying‐Wei Lan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ying‐Wei Lan has authored 40 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Ying‐Wei Lan's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Neonatal Respiratory Health Research (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Ying‐Wei Lan is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Neonatal Respiratory Health Research (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Ying‐Wei Lan collaborates with scholars based in Taiwan, United States and Malaysia. Ying‐Wei Lan's co-authors include Chuan‐Mu Chen, Kowit‐Yu Chong, Kong‐Bung Choo, Han-Pin Kuo, Hsiao‐Ling Chen, Chih‐Ching Yen, Tsung‐Teng Huang, Hsin‐Chih Lai, Yun‐Fei Ko and Jan Martel and has published in prestigious journals such as Nature Communications, Scientific Reports and The FASEB Journal.

In The Last Decade

Ying‐Wei Lan

36 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying‐Wei Lan Taiwan 17 337 245 204 154 89 40 837
Sehwan Shim South Korea 22 327 1.0× 163 0.7× 95 0.5× 111 0.7× 195 2.2× 52 986
Shunliang Yang China 16 380 1.1× 275 1.1× 334 1.6× 339 2.2× 106 1.2× 33 1.2k
Shaoheng Zhang China 19 371 1.1× 77 0.3× 228 1.1× 299 1.9× 55 0.6× 46 952
Sung Won Kwon South Korea 18 392 1.2× 121 0.5× 105 0.5× 273 1.8× 99 1.1× 54 1.0k
Mohamed I. Saad Australia 17 321 1.0× 148 0.6× 71 0.3× 146 0.9× 127 1.4× 34 791
Elena Doldo Italy 16 286 0.8× 87 0.4× 101 0.5× 140 0.9× 92 1.0× 28 840
Hanyu Wang China 19 514 1.5× 103 0.4× 151 0.7× 120 0.8× 147 1.7× 73 1.1k
Jianda Dong China 18 374 1.1× 235 1.0× 62 0.3× 88 0.6× 65 0.7× 36 946
Weizhen Wu China 21 603 1.8× 175 0.7× 249 1.2× 339 2.2× 85 1.0× 49 1.4k
Fei Zhu China 13 261 0.8× 75 0.3× 116 0.6× 101 0.7× 115 1.3× 21 782

Countries citing papers authored by Ying‐Wei Lan

Since Specialization
Citations

This map shows the geographic impact of Ying‐Wei Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Wei Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Wei Lan more than expected).

Fields of papers citing papers by Ying‐Wei Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Wei Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Wei Lan. The network helps show where Ying‐Wei Lan may publish in the future.

Co-authorship network of co-authors of Ying‐Wei Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Wei Lan. A scholar is included among the top collaborators of Ying‐Wei Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Wei Lan. Ying‐Wei Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Ying‐Wei, et al.. (2025). Triptolide Inhibits Epileptic Seizures by Rescuing the Neuroinflammation‐Related GABAergic Dysfunction in Mice. CNS Neuroscience & Therapeutics. 31(8). e70586–e70586.
2.
Wang, Guolun, Ying‐Wei Lan, Zicheng Deng, et al.. (2024). FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO Molecular Medicine. 16(5). 1063–1090. 7 indexed citations
3.
Lan, Ying‐Wei, et al.. (2024). The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment. Cancers. 16(4). 756–756. 13 indexed citations
4.
Lan, Ying‐Wei, Wanru Chen, Ying-Cheng Chen, et al.. (2024). Aldo-keto reductase family 1 member A1 (AKR1A1) exerts a protective function in alcohol-associated liver disease by reducing 4-HNE accumulation and p53 activation. Cell & Bioscience. 14(1). 18–18. 9 indexed citations
5.
Lan, Ying‐Wei, et al.. (2024). Transplantation of alveolar macrophages improves the efficacy of endothelial progenitor cell therapy in mouse model of bronchopulmonary dysplasia. American Journal of Physiology-Lung Cellular and Molecular Physiology. 327(1). L114–L125.
6.
Lan, Ying‐Wei, Shuyang Zhao, Zicheng Deng, et al.. (2023). Lung endothelial cells regulate pulmonary fibrosis through FOXF1/R-Ras signaling. Nature Communications. 14(1). 2560–2560. 55 indexed citations
7.
Yen, Chih‐Ching, Hsiao‐Ling Chen, Ying‐Wei Lan, et al.. (2023). Therapeutic effects of kefir peptides on adjuvant-induced arthritis in rats through anti-inflammation and downregulation of matrix metalloproteinases. Life Sciences. 317. 121411–121411. 12 indexed citations
8.
Liao, Chun-Huei, Chih‐Ching Yen, Hsiao‐Ling Chen, et al.. (2023). Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway. Antioxidants. 12(9). 1724–1724. 11 indexed citations
9.
Yen, Chih‐Ching, Hueng‐Chuen Fan, Jen‐Kun Chen, et al.. (2023). In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment. International Journal of Molecular Sciences. 24(22). 16411–16411. 1 indexed citations
10.
Chen, Ying-Cheng, Ying‐Wei Lan, Chih‐Ching Yen, et al.. (2022). Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model. Stem Cell Research & Therapy. 13(1). 235–235. 14 indexed citations
11.
Yen, Chih‐Ching, Yaowen Liu, Ying‐Wei Lan, et al.. (2022). Therapeutic Effects of Kefir Peptides on Hemophilia-Induced Osteoporosis in Mice With Deficient Coagulation Factor VIII. Frontiers in Cell and Developmental Biology. 10. 794198–794198. 9 indexed citations
12.
Lan, Ying‐Wei, Yu‐Hsuan Chen, Min‐Yu Tu, et al.. (2022). Kefir peptides promote osteogenic differentiation to enhance bone fracture healing in rats. Life Sciences. 310. 121090–121090. 9 indexed citations
13.
Chen, Hsiao‐Ling, Ying‐Wei Lan, Min‐Yu Tu, et al.. (2021). Kefir peptides exhibit antidepressant-like activity in mice through the BDNF/TrkB pathway. Journal of Dairy Science. 104(6). 6415–6430. 19 indexed citations
14.
Tung, Min‐Che, Ying‐Wei Lan, Hsiao‐Ling Chen, et al.. (2020). Kefir peptides alleviate high-fat diet-induced atherosclerosis by attenuating macrophage accumulation and oxidative stress in ApoE knockout mice. Scientific Reports. 10(1). 8802–8802. 33 indexed citations
15.
Huang, Tsung‐Teng, Ying‐Wei Lan, Chuan‐Mu Chen, et al.. (2019). Antrodia cinnamomea induces anti-tumor activity by inhibiting the STAT3 signaling pathway in lung cancer cells. Scientific Reports. 9(1). 5145–5145. 22 indexed citations
16.
Lan, Ying‐Wei, Chih‐Ching Yen, Tsung‐Teng Huang, et al.. (2019). Predifferentiated amniotic fluid mesenchymal stem cells enhance lung alveolar epithelium regeneration and reverse elastase-induced pulmonary emphysema. Stem Cell Research & Therapy. 10(1). 163–163. 23 indexed citations
17.
Chen, Hsiao‐Ling, Chih‐Ching Yen, Ying‐Wei Lan, et al.. (2019). Kefir peptides alleviate particulate matter <4 μm (PM4.0)-induced pulmonary inflammation by inhibiting the NF-κB pathway using luciferase transgenic mice. Scientific Reports. 9(1). 11529–11529. 25 indexed citations
18.
Lan, Ying‐Wei, et al.. (2015). Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol promotes angiogenesis in a mouse model. Cell Stress and Chaperones. 20(4). 643–652. 13 indexed citations
19.
Lan, Ying‐Wei, Lih-Geeng Chen, Kong‐Bung Choo, et al.. (2015). Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol alleviates elastase-induced emphysema in a mouse model. Cell Stress and Chaperones. 20(6). 979–989. 32 indexed citations
20.
Lan, Ying‐Wei. (2003). The correlation between optic nerve head topographic measurements, peripapillary nerve fibre layer thickness, and visual field indices in glaucoma. British Journal of Ophthalmology. 87(9). 1135–1141. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026